These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 11483392)

  • 1. Lafora's disease: towards a clinical, pathologic, and molecular synthesis.
    Minassian BA
    Pediatr Neurol; 2001 Jul; 25(1):21-9. PubMed ID: 11483392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.
    Minassian BA; Ianzano L; Meloche M; Andermann E; Rouleau GA; Delgado-Escueta AV; Scherer SW
    Neurology; 2000 Aug; 55(3):341-6. PubMed ID: 10932264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lafora's disease presenting with progressive myoclonus epilepsy].
    Béjot Y; Lemesle-Martin M; Contégal F; Graule-Petot A; Thauvin C; Aubriot-Lorton MH; Moreau T; Giroud M
    Rev Neurol (Paris); 2007 Oct; 163(10):975-8. PubMed ID: 18033035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive myoclonic epilepsy secondary to Lafora's body disease].
    Potes T; Galicchio S; Rosso B; Besocke G; García MDC; Avalos JC
    Medicina (B Aires); 2018; 78(6):436-439. PubMed ID: 30504111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
    Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
    Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.
    Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy.
    Singh S; Sethi I; Francheschetti S; Riggio C; Avanzini G; Yamakawa K; Delgado-Escueta AV; Ganesh S
    J Med Genet; 2006 Sep; 43(9):e48. PubMed ID: 16950819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lafora disease with a fatal outcome].
    Krakhmal NV; Vasilchenko DV; Vtorushin SV
    Arkh Patol; 2022; 84(6):61-66. PubMed ID: 36469720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.
    Ki CS; Kong SY; Seo DW; Hong SB; Kim HJ; Kim JW
    J Hum Genet; 2003; 48(1):51-4. PubMed ID: 12560877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.
    Ganesh S; Puri R; Singh S; Mittal S; Dubey D
    J Hum Genet; 2006; 51(1):1-8. PubMed ID: 16311711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of Lafora's disease associated with cardiac arrhythmia.
    Oksel F; Tekgül H; Genç S; Ozyürek R; Akalin T; Tütütüncüoğlu S
    J Child Neurol; 1999 Nov; 14(11):745-6. PubMed ID: 10593553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive myoclonus epilepsy with polyglucosan bodies: Lafora disease.
    Minassian BA
    Adv Neurol; 2002; 89():199-210. PubMed ID: 11968446
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in lafora progressive myoclonus epilepsy.
    Delgado-Escueta AV
    Curr Neurol Neurosci Rep; 2007 Sep; 7(5):428-33. PubMed ID: 17764634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy.
    Minassian BA; Lee JR; Herbrick JA; Huizenga J; Soder S; Mungall AJ; Dunham I; Gardner R; Fong CY; Carpenter S; Jardim L; Satishchandra P; Andermann E; Snead OC; Lopes-Cendes I; Tsui LC; Delgado-Escueta AV; Rouleau GA; Scherer SW
    Nat Genet; 1998 Oct; 20(2):171-4. PubMed ID: 9771710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel exon 3 mutation in a Tunisian patient with Lafora's disease.
    Khiari HM; Lesca G; Malafosse A; Mrabet A
    J Neurol Sci; 2011 May; 304(1-2):136-7. PubMed ID: 21371719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progressive myoclonic epilepsy type Lafora].
    Chemaly R; Checrallah A; Trak-Smayra V; El-Kallab K; Chemaly E
    J Med Liban; 2001; 49(3):170-2. PubMed ID: 12187920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laforin is a cell membrane and endoplasmic reticulum-associated protein tyrosine phosphatase.
    Minassian BA; Andrade DM; Ianzano L; Young EJ; Chan E; Ackerley CA; Scherer SW
    Ann Neurol; 2001 Feb; 49(2):271-5. PubMed ID: 11220751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of zonisamide in Lafora's disease case and brief review of its use in progressive myoclonic epilepsy].
    Rubio-Nazábal E; Álvarez-Pérez P; Cores-Bartolomé C; Lema-Facal T
    Rev Neurol; 2022 Sep; 75(6):159-163. PubMed ID: 36098450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
    Nitschke S; Sullivan MA; Mitra S; Marchioni CR; Lee JPY; Smith BH; Ahonen S; Wu J; Chown EE; Wang P; Petković S; Zhao X; DiGiovanni LF; Perri AM; Israelian L; Grossman TR; Kordasiewicz H; Vilaplana F; Iwai K; Nitschke F; Minassian BA
    Brain; 2022 Jul; 145(7):2361-2377. PubMed ID: 35084461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.